ZNF853

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ZNF853 mutation is significantly associated with the drug of many other genes, with 35 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ZNF853-associated genes across cancer lineages are AZD8055, 50869, and Zibotentan. Each is linked with ZNF853 in more than 1 cancer types. Because this analysis shows association rather than direction, both ZNF853-to-partner and partner-to-ZNF853 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, AZD8055 grouped by ZNF853-low versus ZNF853-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ZNF853→partner) and Y-score (partner→ZNF853) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEAZD8055 →+0.559+2.807.020.04631
LARGE_INTESTINE50869 →+0.402+2.871.045.02131
LARGE_INTESTINEZibotentan →+0.192+2.874.046.02131
LARGE_INTESTINEKIN001-244 →+0.383+2.807.048.02631
LARGE_INTESTINETorin 2 →+0.569+2.877.025.02031
LARGE_INTESTINEETP-45835 →+0.283+2.874.012.02131
Each partner links to its Q-omics profile. Showing the 6 strongest of 35 associations by consensus.

AZD8055 by ZNF853 expression — LARGE_INTESTINE

Box plot of AZD8055 in ZNF853-low vs ZNF853-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration